June Virtual Investor Forum - Thursday, June 15, 2023

Thursday, Jun 15 / 2023 - Virtual Forum
  • Thursday, June 15, 2023
  • 10:00 AM - 01:30 PM PST
  • → Online here
  • Access will be granted upon approval

The forum will feature 20-minute presentations (including Q&A) from a curated selection of exciting start-up companies, all of whom have been carefully selected through our screening processes. You will also see an updated presentation from a past presenting company.

10:00 AM               Welcome: Connie Harrell, President, Keiretsu Forum SoCal Intro                                              

Entrepreneur Presentations:

 10:10 AM               Another Tomorrow

Another Tomorrow was created in response to the values of the curious, compassionate global citizen seeking elevated, thoughtful design, education, and tools for advocacy. After 3 years,

10:30 AM               Maxwell Biosciences

 Maxwell Biosciences technology is backed by over $40M in government grants & private investments, and has developed what DARPA calls a "synthetic immune system" - a molecule that is able to tackle viruses, all tested bacteria and all tested fungi (all with a single compound). Their drug discovery technology has the potential to replace all current antibiotics, safely and affordably without developing resistance - a $40B+ revenue opportunity.

10:50 AM               Diamond Age 3D

Diamond Age has developed industrial-scale robotics and 3D printing to drive affordability for first-time home buyers - AKA - building robots bigger than houses to build houses.

11:10 AM               MAA Laboratories

MAA uses its patented NanoContTM platform technology to develop novel medicines with meaningful clinical benefits over currently marketed medicines. MAA's products are approved by the FDA based on a defined regulatory pathway that does not require safety, efficacy, or toxicity studies.

Entrepreneur Updates: 

11:30 AM                NuvOx Pharma

NuvOx Pharma is a clinical stage biotechnology company developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role.

11:35 AM              DRS.LINQ.mHeart

mHeart facilitates the chronic management of heart disease through remote monitoring while enabling mobile triage during episodes of chest discomfort